Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Cellectis S.A. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +5 vs. Q2 2022
- Shares held
- 10.3M
- −530.7K (−4.9%) vs. Q2 2022
- Total value
- $23.6M
- −$7.01M (−22.9%) vs. Q2 2022
- New holders
- 9
- 11 more added
- Sold out
- 4
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.6M |
| Q4 2023 | 34 | $30.5M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.7M |
| Q1 2022 | 51 | $56.4M |
| Q4 2021 | 57 | $126.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $252.6M |
| Q1 2021 | 81 | $309.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 2,683,633 | $6.15M | 1.30% | −107,977−3.9% | Reduced |
| Credit Suisse AG | 1,438,255 | $3.29M | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 1,343,467 | $3.08M | 0.00% | −4,845−0.4% | Reduced |
| Baillie Gifford & Co | 788,837 | $1.81M | 0.00% | −92,095−10.5% | Reduced |
| Millennium Management LLC | 573,841 | $1.31M | 0.00% | +120,900+26.7% | Added |
| Capital International Investors | 448,804 | $1.03M | 0.00% | −132,233−22.8% | Reduced |
| Jane Street Group, LLC | 343,894 | $819.0K | 0.00% | −146,336−29.9% | Reduced |
| BlackRock Inc. | 281,701 | $645.0K | 0.00% | −8,324−2.9% | Reduced |
| D. E. Shaw & Co., Inc. | 278,327 | $637.0K | 0.00% | +6,778+2.5% | Added |
| State Street Corp | 262,368 | $601.0K | 0.00% | +8,643+3.4% | Added |
| Capital World Investors | 250,000 | $573.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $520.0K | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 210,659 | $482.0K | 0.00% | +24,641+13.2% | Added |
| Woodline Partners LP | 169,802 | $389.0K | 0.01% | +169,802 | New |
| KBC Group NV | 163,447 | $374.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 108,744 | $249.0K | 0.00% | −5,697−5.0% | Reduced |
| Kettle Hill Capital Management, LLC | 104,596 | $240.0K | 0.06% | +104,596 | New |
| Oppenheimer & Co Inc | 91,963 | $211.0K | 0.00% | +16,330+21.6% | Added |
| Vanguard Group Inc | 85,864 | $197.0K | 0.00% | +85,864 | New |
| Morgan Stanley | 75,953 | $174.0K | 0.00% | −23,998−24.0% | Reduced |
| Hudson Bay Capital Management LP | 74,532 | $171.0K | 0.00% | −200,468−72.9% | Reduced |
| WS Management LLLP | 50,907 | $117.0K | 0.02% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 45,519 | $104.0K | 0.00% | +24,580+117.4% | Added |
| Baird Financial Group, Inc. | 32,640 | $74.0K | 0.00% | +32,640 | New |
| Bank of America Corp | 19,063 | $44.0K | 0.00% | −2,753−12.6% | Reduced |
| Balyasny Asset Management LLC | 18,352 | $42.0K | 0.00% | +18,352 | New |
| Wells Fargo & Company | 17,229 | $40.0K | 0.00% | +5,400+45.7% | Added |
| Two Sigma Advisers, LP | 14,900 | $34.0K | 0.00% | −400−2.6% | Reduced |
| Vontobel Holding Ltd. | 14,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,303 | $30.0K | 0.00% | +13,303 | New |
| Citadel Advisors LLC | 12,358 | $28.0K | 0.00% | −11,231−47.6% | Reduced |
| SEI Investments Co | 10,977 | $25.0K | 0.00% | +10,977 | New |
| Princeton Capital Management LLC | 10,594 | $24.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,776 | $24.0K | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 8 | $24.0K | 0.00% | −4−33.3% | Reduced |
| Tower Research Capital LLC (TRC) | 7,062 | $16.0K | 0.00% | +699+11.0% | Added |
| Advisor Group Holdings, Inc. | 6,403 | $15.0K | 0.00% | −400−5.9% | Reduced |
| National Bank of Canada | 3,600 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,907 | $8.00K | 0.00% | +3,513+891.6% | Added |
| JPMorgan Chase & Co | 1,350 | $3.00K | 0.00% | +407+43.2% | Added |
| Assetmark, Inc | 1,140 | $3.00K | 0.00% | +275+31.8% | Added |
| Citigroup Inc | 253 | $1.00K | 0.00% | −71−21.9% | Reduced |
| Barclays PLC | 650 | $1.00K | 0.00% | +650 | New |
| TD Waterhouse Canada Inc. | 360 | $832 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 56 | $0 | 0.00% | −52−48.1% | Reduced |
| Parkside Financial Bank & Trust | 147 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 168 | $0 | 0.00% | +168 | New |
| Bpifrance SA | 0 | $0 | 0.00% | −425,726−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,366−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −31−100.0% | Sold out |